Quality · Certificates of analysis
Every lot,
on the record.
Search by compound, lot, or release date. Each certificate is the immutable record of identity, purity, and release for the corresponding shipment.
312
Released
99.4%
Mean purity
48h
Avg release
0.7%
Rejection rate
Supporting documentation
The methods, the SOP, the handling rules.
- Download PDF
Analytical methodology
HPLC, mass-spec, LAL — the full method set we run per lot.
- Download PDF
QA standard operating procedure
Release criteria, lot-locking, deviation handling.
- Download PDF
Storage & handling guide
Reconstitution, cold-chain, expected stability.
- Released 2026-04-12
NXG-001 · Bioactive Peptide
Lot · NXG-2026-A8
- Purity
- 99.42%
- Endotoxin
- <0.18 EU/mg
- Analyst
- M. Reyes, M.S.
- Released 2026-03-28
NXG-002 · Bioactive Peptide
Lot · NXG-2026-B4
- Purity
- 99.18%
- Endotoxin
- <0.21 EU/mg
- Analyst
- L. Chen, Ph.D.
- Released 2026-04-04
NXG-003 · Bioactive Peptide
Lot · NXG-2026-C2
- Purity
- 99.61%
- Endotoxin
- <0.14 EU/mg
- Analyst
- M. Reyes, M.S.
3 certificates · current release window